Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Dual trigger versus hCG trigger in GnRH antagonist cycles for poor ovarian response
ChiCTR2200061977Phase 4Completed
- Sponsor
- CITIC Xiangya Reproductive and Genetic Hospital
- Start
- Jul 2022
- Modality
- Recombinant Proteins and Enzymes
- Countries
- 1
01
Overview
Phase 4, randomised trial of human chorionic gonadotropin and gonadotropin-releasing hormone agonist in infertility and poor ovarian response (POR) (2 arms), sponsored by CITIC Xiangya Reproductive and Genetic Hospital. Primary endpoint: Number of oocytes retrieved. Started Jul 2022; status: completed.
02
Drugs
human chorionic gonadotropingonadotropin-releasing hormone agonist
03
Conditions
infertilitypoor ovarian response (POR)
Beyond the preview
Go deeper on ChiCTR2200061977.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ChiCTR2200061977.